Renal cancer: From current evidence to future perspectives

doi:10.1016/j.ajur.2022.05.001

Asian Journal of Urology, 2022, 9 (3): 199-200 doi: 10.1016/j.ajur.2022.05.001

Editorials

Current Issue | Archive | Adv Search

Renal cancer: From current evidence to future perspectives

Cristian Fiori^*(

),Francesco Porpiglia

Department of Oncology-University of Turin, San Luigi Hospital, Orbassano, Turin, Italy

Abstract
Related Citation (0)

[1]	Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 2018; 103:356e87.
[2]	Su ZT, Patel HD, Huang MM, Alam R, Cheaib JG, Pavlovich CP, et al. Active surveillance versus immediate intervention for small renal masses: a cost-effectiveness and clinical decision analysis. J Urol 2022: 101097 https://doi.org/10.1097/JU.0000000000002812. Epub ahead of print
[3]	Patel AK, Rogers CG, Johnson A, Noyes SL, Qi J, Miller D, et al. Michigan Urological Surgery Improvement Collaborative. Initial observation of a large proportion of patients presenting with clinical stage T1 renal masses: results from the MUSIC-KIDNEY Statewide Collaborative. Eur Urol Open Sci 2020; 23:13e9.
[4]	Okhunov Z, Gorin MA, Jefferson FA, Afyouni AS, Allaf ME, Pierorazio PM, et al. Can preoperative renal mass biopsy change clinical practice and reduce surgical intervention for small renal masses? Urol Oncol 2021; 39:735.e17e735.e23, https://doi.org/10.1016/j.urolonc.2021.05.024.
[5]	Capitanio U, Becker F, Blute ML, Mulders P, Patard JJ, Russo P, et al. Lymph node dissection in renal cell carcinoma. Eur Urol 2011; 60:1212e20.
[6]	Erdem S, Capitanio U, Campi R, Mir MC, Roussel E, Pavan N, et al. European Association of Urology (EAU)-Young Academic Urologists (YAU) Renal Cancer Working Group. External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: A multi-institutional analysis. Urol Oncol 2022; 40:198.e9e198. e17. https://doi.org/10.1016/j.urolonc.2022.01.006.
[7]	Hemminki O, Perlis N, Bjorklund J, Finelli A, Zlotta AR, Hemminki A. Treatment of advanced renal cell carcinoma: immunotherapies have demonstrated overall survival benefits while targeted therapies have not. Eur Urol Open Sci 2020; 22: 61e73.
[8]	Baboudjian M, Gondran-Tellier B, Khene Z, Bigot P, Mejean A, Lang H, et al. Predictive factors of recurrence after surgery in patients with non-metastatic renal cell carcinoma with venous tumor thrombus (UroCCR-56 Study). World J Urol 2021. https://doi.org/10.1007/s00345-021-03640-6.
[9]	Tran J, Ornstein MC. Clinical review on the management of metastatic renal cell carcinoma. JCO Oncol Pract 2021: OP2100419. https://doi.org/10.1200/OP.21.00419.
[10]	Checcucci E, Autorino R, Cacciamani GE, Amparore D, De Cillis S, Piana A, et al. Uro-technology and SoMe working group of the Young academic urologists working party of the European association of urology. Artificial intelligence and neural networks in urology: current clinical applications. Minerva Urol Nefrol 2020; 72:49e57.
[11]	Syed K, Sleeman W, Soni P, Hagan M, Palta J, Kapoor R, et al. Machine-learning models for multicenter prostate cancer treatment plans. J Comput Biol 2021; 28:166e84. doi: 10.1089/cmb.2020.0188
[12]	Hamacher A, Kim SJ, Cho ST, Pardeshi S, Lee SH, Eun SJ, et al. Application of virtual, augmented, and mixed reality to urology. Int Neurourol J 2016; 20:172e81. pmid: 27706017
[13]	Suarez-Ibarrola R, Miernik A. Prospects and challenges of artificial intelligence and computer science for the future of urology. World J Urol 2020; 38:2325e7. doi: 10.1007/s00345-020-03428-0 pmid: 32910230
[14]	Checcucci E, Amparore D, Pecoraro A, Peretti D, Aimar R, DE Cillis S, et al. 3D mixed reality holograms for preoperative surgical planning of nephron-sparing surgery: evaluation of surgeons’ perception. Minerva Urol Nephrol 2021; 73:367e75. doi: 10.23736/S2724-6051.19.03610-5 pmid: 31486325
[15]	Porpiglia F, Checcucci E, Amparore D, Piramide F, Volpi G, Granato S, et al. Three-dimensional augmented reality robotassisted partial nephrectomy in case of complex tumours(PADUA _10):a new intraoperative tool overcoming the ultrasound guidance. Eur Urol 2020; 78:229e38. doi: 10.1016/j.eururo.2019.11.024
[16]	Porpiglia F, Amparore D, Checcucci E, Autorino R, Manfredi M, Iannizzi G, et al. Current use of three-dimensional model technology in urology: a road map for personalised surgical planning. Eur Urol Focus 2018; 4:652e6.